Bajaj Healthcare

29
Strong Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE411U01027
  • NSEID: BAJAJHCARE
  • BSEID: 539872
INR
299.05
-14.45 (-4.61%)
BSENSE

Mar 27

BSE+NSE Vol: 2.36 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 14.61% vs -26.69% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 8.08% vs -31.52% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is -5.98% vs 69.01% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 399.64% vs -122.55% in Mar 2024

Compare Profit and Loss Results of Bajaj Healthcare
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
542.00
462.00
80.00
17.32%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
542.00
462.00
80.00
17.32%
Expenditure (Ex Depriciation)
Stock Adjustments
-20.00
-10.00
-10.00
-100.00%
Raw Materials Consumed
307.00
317.00
-10.00
-3.15%
Power & Fuel Cost
22.00
5.00
17.00
340.00%
Employee Cost
57.00
52.00
5.00
9.62%
Operating Expenses
63.00
2.00
61.00
3,050.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
6.00
34.00
-28.00
-82.35%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
6.00
4.00
2.00
50.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
460.00
409.00
51.00
12.47%
Operating Profit (PBDIT) excl Other Income
82.00
53.00
29.00
54.72%
Other Income
19.00
17.00
2.00
11.76%
Operating Profit (PBDIT)
101.00
70.00
31.00
44.29%
Interest
27.00
0.00
27.00
0%
Profit before Depriciation and Tax
73.00
69.00
4.00
5.80%
Depreciation
27.00
5.00
22.00
440.00%
Profit Before Taxation & Exceptional Items
46.00
64.00
-18.00
-28.12%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
46.00
64.00
-18.00
-28.12%
Provision for Tax
3.00
15.00
-12.00
-80.00%
Profit After Tax
42.00
48.00
-6.00
-12.50%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
267.00
102.00
165.00
161.76%
Profit Available for appropriations
310.00
151.00
159.00
105.30%
Appropriations
310.00
151.00
159.00
105.30%
Equity Dividend (%)
20%
0%
20.00
Earnings Per Share
13.29
0.57
12.72
2,231.58%
Profit And Loss - Net Sales
Net Sales 542.60 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 14.61% vs -26.69% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 82.43 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 8.08% vs -31.52% in Mar 2024

Profit And Loss - Interest
Interest 27.90 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -5.98% vs 69.01% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 42.93 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 399.64% vs -122.55% in Mar 2024